Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases
Disease Category: Vascular Diseases
Trial Information
Caffeine Intake - Adults
People with coronary artery disease are asked to participate in a research study being conducted by North Shore University Hospital.
You may be eligible to participate in this study if you:
- Are male or female at least 18 years of age
- Are able to ingest caffeinated food or beverages regularly (at least the equivalent of one cup of caffeinated coffee daily)
- Agree not to ingest any caffeine or other foods containing methylxanthine at least 24 hours prior to each study visit
You may not participate in this study if you:
- Have had a prior history of heart transplantationAre allergic or intolerant to aminophylline, regadenoson, and /or caffeine
- Have a history of diabetes associated with gastric disorders and/ or emptying
- Have a history of smoking, regardless of frequency, tobacco type or method of intake, within 3 months prior to first dose of regadenoson
Diane Delliliune, Study Coordinator
Biomedical Research Alliance of New York
North Shore University Hospital
300 Community Drive
Manhasset, NY 11030
Phone: 516-562-2345
Fax: 516-562-3993
EMail: ddellili@nshs.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
